Rettelse i tidsskrift

• Tale Jeanette Meinich; Jone Trovik (2020). Erratum: Early maternal weight gain as a risk factor for SGA in pregnancies with hyperemesis gravidarum: A 15-year hospital cohort study (BMC Pregnancy and Childbirth (2020) 20:255 DOI: 10.1186/s12884-020-02947-3). (ekstern lenke)
• Hilde Eide Lien; Hege Fredriksen Berg; Mari Kyllesø Halle et al. (2023). Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595] (eBioMedicine (2023) 92, (S2352396423001603), (10.1016/j.ebiom.2023.104595)). (ekstern lenke)
• Hege Fredriksen Berg; Marta Espevold Hjelmeland; Hilde Eide Lien et al. (2021). Author Correction: Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis (Communications Medicine, (2021), 1, 1, (20), 10.1038/s43856-021-00019-x). (ekstern lenke)

Lærebok

• Ulla Breth Knudsen; Kristina Gemzell-Danielsson; Jone Trovik et al. (2020). Obstetrics and Gynecology. NFOG textbook for medical students. (ekstern lenke)

Vitenskapelig artikkel

• Hege Fredriksen Berg; Zhenlin Ju; Madeleine Myrvold et al. (2020). Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma. (ekstern lenke)
• Mac Versluis; Annechien Plat; Marco de Bruyn et al. (2018). L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition. (ekstern lenke)
• Henrica Maria Johanna Werner; Anna Berg; Elisabeth Wik et al. (2013). ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. (ekstern lenke)
• Even Birkeland; Elisabeth Wik; Siv Mjøs et al. (2012). KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. (ekstern lenke)
• Casper Reijnen; Evangelia Gogou; Nicole C.M. Visser et al. (2020). Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study. (ekstern lenke)
• Casper Reijnen; Willem Jan van Weelden; Martijn S.J.P. Arts et al. (2019). Poor outcome in hypoxic endometrial carcinoma is related to vascular density. (ekstern lenke)
• Timothy H.T. Cheng; Deborah Thompson; Jodie Painter et al. (2015). Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. (ekstern lenke)
• Hilde Erdal; Lone Holst; Kristine Heitmann et al. (2024). Guidelines for Treatment of Hyperemesis Gravidarum and Implementation in Clinical Practice in Norway: A Descriptive Study. (ekstern lenke)
• Ingunn Stefansson; Maria B Ræder; Elisabeth Wik et al. (2015). Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. (ekstern lenke)
• David Erik Forsse; Hege Fredriksen Berg; Olivera Bozickovic et al. (2020). Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer. (ekstern lenke)
• Elisabeth Wik; Maria B Ræder; Camilla Krakstad et al. (2013). Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. (ekstern lenke)
• Elin Strand; Ingvild Løberg Tangen; Kristine Eldevik Fasmer et al. (2019). Blood metabolites associate with prognosis in endometrial cancer. (ekstern lenke)
• Karen Klepsland Mauland; Jone Trovik; Elisabeth Wik et al. (2011). High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. (ekstern lenke)
• Louis J.M. Van Der Putten; Nicole C.M. Visser; Koen Van de Vijver et al. (2016). L1CAM expression in endometrial carcinomas: An ENITEC collaboration study. (ekstern lenke)
• Kristine Eldevik Fasmer; Atle Bjørnerud; Sigmund Ytre-Hauge et al. (2018). Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. (ekstern lenke)
• Nicole C.M. Visser; Louis J.M. van der Putten; Alex van Egerschot et al. (2019). Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study. (ekstern lenke)
• Karen Klepsland Mauland; Øyvin Andre Solberg Eng; Sigmund Ytre-Hauge et al. (2017). High visceral fat percentage is associated with poor outcome in endometrial cancer. (ekstern lenke)
• Judith Krossøy Pedersen; Cecilie Sira; Jone Trovik (2021). Handheld transabdominal ultrasound, after limited training, may confirm first trimester viable intrauterine pregnancy: a prospective cohort study. (ekstern lenke)
• Hilde Renate Haugen Engerud; Ingvild Løberg Tangen; Ansgar Berg et al. (2014). High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. (ekstern lenke)
• Tina Fonnes; Jone Trovik; Per-Henrik D. Edqvist et al. (2018). Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. (ekstern lenke)
• Ingfrid S. Haldorsen; Anna Berg; Henrica Maria Johanna Werner et al. (2012). Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas. (ekstern lenke)
• Helen Mackay; Elizabeth A. Eisenhauer; Suzanne Kamel-Reid et al. (2014). Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer. (ekstern lenke)
• Luis G. Carvajal-Carmona; Tracy A. O'Mara; Jodie N. Painter et al. (2015). Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. (ekstern lenke)
• Ingfrid S. Haldorsen; Ingunn Stefansson; Renate Grüner et al. (2014). Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas. (ekstern lenke)
• Elisabeth Sofie Birkeland; Guro Stokke; Randi Julie Tangvik et al. (2015). Norwegian PUQE (pregnancy-unique quantification of emesis and nausea) identifies patients with hyperemesis gravidarum and poor nutritional intake: A prospective cohort validation study. (ekstern lenke)
• Amit Dutt; Helga Salvesen; Tzu-Hsiu Chent et al. (2008). Drug-sensitive FGFR2 mutations in endometrial carcinoma. (ekstern lenke)
• Marta Espevold Hjelmeland; Hilde Eide Lien; Hege Fredriksen Berg et al. (2024). Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer. (ekstern lenke)
• Njål Gjærde Lura; Kari Strøno Wagner-Larsen; David Erik Forsse et al. (2022). What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?. (ekstern lenke)
• Karen Klepsland Mauland; Zhenlin Ju; Ingvild Løberg Tangen et al. (2017). Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. (ekstern lenke)
• Tarjei Sveinsgjerd Hveem; Tormund Salvesen Njølstad; Birgitte Nielsen et al. (2016). Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer. (ekstern lenke)
• Karen Klepsland Mauland; Elisabeth Wik; Erling Andre Høivik et al. (2016). Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. (ekstern lenke)
• Geir Bredholt; Monica Mannelqvist; Ingunn Stefansson et al. (2015). Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses. (ekstern lenke)
• Vikram Rao Bollineni; Sigmund Ytre-Hauge; Ankush Gulati et al. (2018). The prognostic value of preoperative FDG-PET/CT metabolic parameters in cervical cancer patients. (ekstern lenke)
• Ingfrid S. Haldorsen; Renate Grüner; Jenny Hild Aase Husby et al. (2013). Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. (ekstern lenke)
• Tina Fonnes; Hege Fredriksen Berg; Therese Bredholt Onyango et al. (2017). Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions. (ekstern lenke)
• Anna Berg; Ankush Gulati; Sigmund Ytre-Hauge et al. (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. (ekstern lenke)
• Timothy H.T. Cheng; Deborah J. Thompson; Tracy A. O'Mara et al. (2016). Five endometrial cancer risk loci identified through genome-wide association analysis. (ekstern lenke)
• Ingvild Løberg Tangen; Reidun Kristin Kopperud; Nicole C.M. Visser et al. (2017). Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients. (ekstern lenke)
• Katharina Bischof; Stian Knappskog; Ingunn Stefansson et al. (2018). High expression of the p53 isoform ? is associated with reduced progression-free survival in uterine serous carcinoma. (ekstern lenke)
• Njål Lura; Kari Strøno Wagner-Larsen; Stian Torkildson Ryste et al. (2025). Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer. (ekstern lenke)
• Tracy A. O'Mara; Dylan M. Glubb; Frédéric Amant et al. (2018). Identification of nine new susceptibility loci for endometrial cancer. (ekstern lenke)
• Siv Mjøs; Henrica Maria Johanna Werner; Even Birkeland et al. (2017). PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer. (ekstern lenke)
• Jirong Long; Wei Zheng; Yong-Bing Xiang et al. (2012). Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. (ekstern lenke)
• Jone Trovik; Karen Klepsland Mauland; Henrica Maria Johanna Werner et al. (2012). Improved survival related to changes in endometrial cancer treatment, a 30-year population based perspective. (ekstern lenke)
• Jone Trovik; Elisabeth Wik; Ingunn Marie Stefansson et al. (2011). Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer. (ekstern lenke)
• Ryan J. Delahanty; Yong-Bing Xiang; Amanda Spurdle et al. (2013). Polymorphisms in inflammation pathway genes and endometrial cancer risk. (ekstern lenke)
• Elisabeth Wik; Jone Trovik; Ole-Erik Iversen et al. (2009). Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting. (ekstern lenke)
• Hilde Renate Engerud; Hege Fredriksen Berg; Madeleine Myrvold et al. (2020). High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer. (ekstern lenke)
• Camilla Krakstad; Jone Trovik; Elisabeth Wik et al. (2012). Loss of GPER identifies new targets for therapy among a subgroup of ER alpha-positive endometrial cancer patients with poor outcome. (ekstern lenke)
• Liva Helleland; Lena Flekke Bergesen; Karen Jakobsen Rinnan et al. (2019). Endometrial ablation; Less is more? Historical cohort study comparing long-term outcomes from two time periods and two treatment modalities for 854 women. (ekstern lenke)
• Kristine Eldevik Fasmer; Ankush Gulati; Julie Andrea Dybvik et al. (2020). Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer. (ekstern lenke)
• Tormund Salvesen Njølstad; Hilde Renate H Engerud; Henrica Maria Johanna Werner et al. (2013). Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. (ekstern lenke)
• Anne Cathrine Staff; Jone Trovik; Ane Gerda Zahl Eriksson et al. (2011). Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer. (ekstern lenke)
• Tina Fonnes; Ingrid Ovidia Moe Telle; David Erik Forsse et al. (2021). Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers. (ekstern lenke)
• Kari Strøno Wagner-Larsen; Njål Gjærde Lura; Øyvind Salvesen et al. (2022). Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer. (ekstern lenke)
• Sigmund Ytre-Hauge; Øyvind Salvesen; Camilla Krakstad et al. (2020). Tumour texture features from preoperative CT predict high-risk disease in endometrial cancer. (ekstern lenke)
• Henrica Maria Johanna Werner; Jone Trovik; Mari Kyllesø Halle et al. (2014). Stathmin Protein Level, a Potential Peredictive Marker for Taxane Treatment Response in Endometrial Cancer. (ekstern lenke)
• Henrica Maria Johanna Werner; Jone Trovik; Janusz Marcickiewicz et al. (2013). A discordant histological risk classification in preoperative and operative biopsy in endometrial cancer is reflected in metastatic risk and prognosis. (ekstern lenke)
• Navneet Kaur Virdee; Emilie Kallåk Ringdal; Heidi Frances Thornhill et al. (2020). Gynekologiske fistler etter kirurgi og strålebehandling. (ekstern lenke)
• Ingvild Løberg Tangen; Henrica Maria Johanna Werner; Anna Berg et al. (2014). Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions. (ekstern lenke)
• Alexander Nima Sharami; Mari Heide Feiring; Ellen Nydal Eide et al. (2025). Long-term patient-reported outcome for surgical management of pelvic organ prolapse: A retrospective cohort study. (ekstern lenke)
• Mari Kyllesø Halle; Marte Sødal; David Erik Forsse et al. (2021). A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. (ekstern lenke)
• Birgitte Nielsen; Andreas Kleppe; Tarjei Sveinsgjerd Hveem et al. (2018). Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers. (ekstern lenke)
• Elisabeth Wik; Even Birkeland; Jone Trovik et al. (2013). High phospho-stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. (ekstern lenke)
• Xueying Yang; Chi Chiu Wang; Wayne Yuk Wai Lee et al. (2017). Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U. (ekstern lenke)
• Ingfrid S. Haldorsen; Jenny Hild Aase Husby; Henrica Maria Johanna Werner et al. (2012). Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists. (ekstern lenke)
• Jenny Hild Aase Husby; Øyvind Salvesen; Inger Johanne Magnussen et al. (2015). Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas. (ekstern lenke)
• Ingrid Vandenput; Jone Trovik; Karin Leunen et al. (2011). Evolution in endometrial cancer evidence from an immunohistochemical study. (ekstern lenke)
• S.W. Vrede; Willem Jan van Weelden; Nicole C.M. Visser et al. (2021). Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer. (ekstern lenke)
• Andreas Kleppe; Fritz Albregtsen; Jone Trovik et al. (2020). Prognostic value of the diversity of nuclear chromatin compartments in gynaecological carcinomas. (ekstern lenke)
• Jone Trovik; Åse Vigdis Vikanes (2016). Hyperemesis Gravidarum is associated with substantial economic burden in addition to severe physical and psychological suffering. (ekstern lenke)
• Ingvild Løberg Tangen; Jennifer Taylor Venereis; Mari Kyllesø Halle et al. (2017). Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions. (ekstern lenke)
• Tormund Salvesen Njølstad; Henrica Maria Johanna Werner; Janusz Marcickiewicz et al. (2017). Late-week surgical treatment of endometrial cancer is associated with worse long-term outcome: Results from a prospective, multicenter study. (ekstern lenke)
• Hilde Renate Engerud; Kirsten Øvergaard Hope; Hege Fredriksen Berg et al. (2019). Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. (ekstern lenke)
• Hilde Erdal; Lone Holst; Kristine Heitmann et al. (2022). Antiemetic treatment of hyperemesis gravidarum in 1,064 Norwegian women and the impact of European warning on metoclopramide: a retrospective cohort study 2002–2019. (ekstern lenke)
• Havjin Jacob; Julie Andrea Dybvik; Sigmund Ytre-Hauge et al. (2021). An mri-based radiomic prognostic index predicts poor outcome and specific genetic alterations in endometrial cancer. (ekstern lenke)
• Elisabeth Wik; Jone Trovik; Kanthida Kusonmano et al. (2014). Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations. (ekstern lenke)
• Hege Fredriksen Berg; Marta Espevold Hjelmeland; Hilde Eide Lien et al. (2021). Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. (ekstern lenke)
• Anna Berg; Kristine Eldevik Fasmer; Karen Klepsland Mauland et al. (2016). Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. (ekstern lenke)
• Deborah J. Thompson; Tracy A. O'Mara; Dylan M. Glubb et al. (2016). CYP19A1 fine-mapping and Mendelian randomization: Estradiol is causal for endometrial cancer. (ekstern lenke)
• Jodie N. Painter; Tracy A. O'Mara; Jyotsna Batra et al. (2015). Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. (ekstern lenke)
• Sigmund Ytre-Hauge; Jenny Hild Aase Husby; Inger Johanne Magnussen et al. (2015). Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. (ekstern lenke)
• Camilla Krakstad; Even Birkeland; Danila Seidel et al. (2012). High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated. (ekstern lenke)
• Jodie N. Painter; Tracy A. O'Mara; Louise Marquart et al. (2016). Genetic risk score mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancer. (ekstern lenke)
• Luis G. Carvajal-Carmona; Tracy A O'Mara; Jodie N Painter et al. (2014). Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. (ekstern lenke)
• Hege Fredriksen Berg; Hilde Renate Engerud; Madeleine Myrvold et al. (2022). Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value. (ekstern lenke)
• Amanda B Spurdle; Shahana Ahmed; Kaltin Ferguson et al. (2011). Genome-wide association study identifies a common variant associated with risk of endometrial cancer. (ekstern lenke)
• Henrica Maria Johanna Werner; Jone Trovik; Janusz Marcickiewicz et al. (2012). Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification. (ekstern lenke)
• Frederik Holst; Henrica Maria Johanna Werner; Siv Mjøs et al. (2019). PIK3CA amplification associates with aggressive phenotype but not markers of AKT-mTOR signaling in endometrial carcinoma. (ekstern lenke)
• Erling Andre Høivik; Kanthida Kusonmano; Mari Kyllesø Halle et al. (2014). Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. (ekstern lenke)
• Tine Cuppens; Daniela Annibali; An Coosemans et al. (2017). Potential targets' analysis reveals dual PI3K/mTOR pathway inhibition as a promising therapeutic strategy for uterine leiomyosarcomas - An ENITEC group initiative. (ekstern lenke)
• Anna Berg; Erling Andre Høivik; Siv Mjøs et al. (2015). Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. (ekstern lenke)
• Ji-Yeon Yang; Henrica Maria Johanna Werner; Jie Li et al. (2016). Integrative protein-based prognostic model for early-stage endometrioid endometrial cancer. (ekstern lenke)
• Nicole C.M. Visser; Henrica Maria Johanna Werner; Camilla Krakstad et al. (2017). Type of vascular invasion in association with progress of endometrial cancer. (ekstern lenke)
• Madeleine Charlotte van der Berg; Hege Fredriksen Berg; Tomasz Stokowy et al. (2024). Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2. (ekstern lenke)
• Lorena Alonso-Alconada; Laura Muinelo-Romay; Kadri Madissoo et al. (2014). Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. (ekstern lenke)
• Tracy A. O'Mara; Dylan M. Glubb; Jodie N. Painter et al. (2015). Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. (ekstern lenke)
• Andreas Kleppe; Fritz Albregtsen; Ljiljana Vlatkovic et al. (2018). Chromatin organisation and cancer prognosis: a pan-cancer study. (ekstern lenke)
• Jone Trovik; Elisabeth Wik; Henrica Maria Johanna Werner et al. (2013). Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. (ekstern lenke)
• Ingrid Vandenput; Jone Trovik; Ignace Vergote et al. (2011). The role of adjuvant chemotherapy in surgical stages I-II serous and clear cell carcinomas and carcinosarcoma of the endometrium a collaborative study. (ekstern lenke)
• Jodie N. Painter; Tracy A. O'Mara; Andrew P. Morris et al. (2018). Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. (ekstern lenke)
• Jone Trovik; Heidi Frances Thornhill; Torvid Kiserud (2016). Incidence of obstetric fistula in Norway: A population-based prospective cohort study. (ekstern lenke)
• Hilde Eide Lien; Hege Fredriksen Berg; Mari Kyllesø Halle et al. (2023). Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease. (ekstern lenke)
• Sigmund Ytre-Hauge; Morteza Esmaeili; Torill Eidhammer Sjøbakk et al. (2017). In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. (ekstern lenke)
• Frederik Holst; Erling Andre Høivik; William J. Gibson et al. (2016). Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth. (ekstern lenke)
• Tale Jeanette Meinich; Jone Trovik (2020). Early maternal weight gain as a risk factor for SGA in pregnancies with hyperemesis gravidarum: A 15-year hospital cohort study. (ekstern lenke)
• Sigmund Ytre-Hauge; Julie Andrea Dybvik; Arvid Lundervold et al. (2018). Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer. (ekstern lenke)
• Hannah Ni Bhriain; Jone Trovik; Elisabeth Wik et al. (2009). Plasma calprotectin concentrations in women with endometrial carcinoma. (ekstern lenke)
• Mari Kyllesø Halle; Akinyemi I Ojesina; Hilde Renate Engerud et al. (2017). Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. (ekstern lenke)
• Philip Egeland; John Espen Gjøen; Jone Trovik et al. (2007). Gynekologiske fistler til urinveier og tarm. (ekstern lenke)
• Kanthida Kusonmano; Mari Kyllesø Halle; Elisabeth Wik et al. (2018). Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer. (ekstern lenke)
• Kristina Yvonne Kathe Lindemann; Aud Elisabeth Farstad Smogeli; Milada Cvancarova Småstuen et al. (2021). Salvage radiation for pelvic relapse after surgically treated endometrial cancer. (ekstern lenke)
• William J. Gibson; Erling Andre Høivik; Mari Kyllesø Halle et al. (2016). The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. (ekstern lenke)
• David Erik Forsse; Ingvild Løberg Tangen; Kristine Eldevik Fasmer et al. (2019). Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling. (ekstern lenke)
• Ingvild Løberg Tangen; Therese Bredholt Onyango; Reidun Kristin Kopperud et al. (2016). Androgen receptor as potential therapeutic target in metastatic endometrial cancer. (ekstern lenke)
• David Erik Forsse; Mark Lewis B Barbero Barbero; Henrica Maria Johanna Werner et al. (2021). Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study. (ekstern lenke)
• Josephine Changole; Viva Combs Thorsen; Jone Trovik et al. (2019). Coping with a disruptive life caused by obstetric fistula: Perspectives from Malawian women. (ekstern lenke)
• Camilla Krakstad; Ingvild Løberg Tangen; Erling Andre Høivik et al. (2015). ATAD2 overexpression links to enrichment of B-MYBtranslational signatures and development of aggressive endometrial carcinoma. (ekstern lenke)
• Helga Birgitte Salvesen; Scott L. Carter; Monica Mannelqvist et al. (2009). Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. (ekstern lenke)
• Julie Andrea Dybvik; Kristine Eldevik Fasmer; Sigmund Ytre-Hauge et al. (2022). MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer. (ekstern lenke)
• Ingvild Løberg Tangen; Kristine Eldevik Fasmer; Gonda F Konings et al. (2018). Blood steroids are associated with prognosis and fat distribution in endometrial cancer. (ekstern lenke)
• Stian Knappskog; Liv Beathe Gansmo; Pål Richard Romundstad et al. (2012). MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk. (ekstern lenke)
• Mari Kyllesø Halle; Ingvild Løberg Tangen; Hege Fredriksen Berg et al. (2017). HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. (ekstern lenke)
• Nuria Eritja; Mariona Jove; Kristine Eldevik Fasmer et al. (2017). Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients. (ekstern lenke)
• Louis J.M. Van Der Putten; Nicole C.M. Visser; Koen Van De Vijver et al. (2018). Added value of estrogen receptor, progesterone receptor, and L1 cell adhesion molecule expression to histology-based endometrial carcinoma recurrence prediction models: An ENITEC Collaboration study. (ekstern lenke)
• Yu Zhao; Yihua Yang; Jone Trovik et al. (2014). A novel Wnt regulatory axis in endometrioid endometrial cancer. (ekstern lenke)
• Kristine Eldevik Fasmer; Erlend Hodneland; Julie Andrea Dybvik et al. (2020). Whole-volume tumor MRI radiomics for prognostic modeling in endometrial cancer. (ekstern lenke)
• Guro Stokke; Bente Leirvåg Gjelsvik; Katrine Trovik Flaatten et al. (2015). Hyperemesis gravidarum, nutritional treatment by nasogastric tube feeding: A 10-year retrospective cohort study. (ekstern lenke)
• Maria B Ræder; Even Birkeland; Jone Trovik et al. (2013). Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. (ekstern lenke)
• Caitlin R Dean; Hyke Bierma; Ria Clarke et al. (2021). A patient-clinician James Lind Alliance partnership to identify research priorities for hyperemesis gravidarum. (ekstern lenke)
• Y. Zhao; Y. Yang; Jone Trovik et al. (2019). Novel PCDH10-Wnt-MALAT1 regulatory axis in endometrioid endometrial adenocarcinoma. (ekstern lenke)
• Tormund Salvesen Njølstad; Jone Trovik; Tarjei Sveinsgjerd Hveem et al. (2015). DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer. (ekstern lenke)
• Jenny Hild Aase Husby; Bernt Christian Reitan; Martin Biermann et al. (2015). Metabolic tumor volume on 18F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients. (ekstern lenke)
• Katrine Trovik Flaatten Børseth; Ganesh Acharya; Torvid Kiserud et al. (2019). Incidence of gynecological fistula and its surgical treatment: A national registry-based study. (ekstern lenke)
• Kristine Eldevik Fasmer; Ankush Gulati; Julie Andrea Dybvik et al. (2022). Preoperative pelvic MRI and 2-[18F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer—time to revisit current imaging guidelines?. (ekstern lenke)
• Jone Trovik; Helga Salvesen; Tine Cuppens et al. (2014). Growth differentiation factor-15 as biomarker in uterine sarcomas. (ekstern lenke)
• Hege Fredriksen Berg; Jone Trovik; Marta Espevold Hjelmeland et al. (2025). Pragmatic preoperative molecular classification of endometrial cancers; Replacing POLE sequencing with hormone receptor staining. (ekstern lenke)
• Stian Knappskog; Jone Trovik; Janusz Marcickiewicz et al. (2012). SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer. (ekstern lenke)
• Ingvild Løberg Tangen; Camilla Krakstad; Mari Kyllesø Halle et al. (2014). Switch in FOXA1 status associates with endometrial cancer progression. (ekstern lenke)
• Puk Meijs-Hermanns; Henrica Maria Johanna Werner; Loes Kooreman et al. (2025). Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma. (ekstern lenke)

Konferanseforedrag

• Sigmund Ytre-Hauge; E Hanson; Arvid Lundervold et al. (2015). Preoperative tumor texture at MRI predicts deep myometrial invasion and non-endometrioid subtype in endometrial carcinomas. (ekstern lenke)
• Lone Holst; Kristine Heitmann; Cathrine Helgestad Kristiansen et al. (2019). European antiemetic regulations (restricting metoclopramide use) increases admission rates due to hyperemesis gravidarum.. (ekstern lenke)

Leserbrev

• Jone Trovik (2014). Ikke "bare" svangerskapskvalme. (ekstern lenke)
• Mari Kyllesø Halle; Henrica Maria Johanna Werner; Camilla Krakstad et al. (2012). Stratification based on high tumour cell content in fresh frozen tissue promotes selection of aggressive endometrial carcinomas. (ekstern lenke)
• Jone Trovik; Åse Vigdis Vikanes (2015). Kvantifisering av svangerskapskvalme :. (ekstern lenke)
• Jone Trovik; Elisabeth Wik; Ingunn Marie Stefansson et al. (2010). Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer. (ekstern lenke)

Konferanseabstrakt

• Ingvild Løberg Tangen; Camilla Krakstad; Henrica Maria Johanna Werner et al. (2013). FOXA1 LOSS IN ENDOMETRIAL CANCER IS ASSOCIATED WITH POOR PROGNOSIS AND ER ALPHA LOSS. (ekstern lenke)
• Henrica Maria Johanna Werner; Jone Trovik; Janusz Marcickiewicz et al. (2012). A discordant histological risk classification in preoperative biopsy and hysterectomy specimens in endometrial cancer is reflected in metastatic risk and prognosis. (ekstern lenke)
• Elisabeth Wik; Maria Rader; Camilla Krakstad et al. (2012). Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. (ekstern lenke)
• Elisabeth Wik; Maria Rader; Camilla Krakstad et al. (2012). Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. (ekstern lenke)

Konferanseposter

• Jone Trovik; Elisabeth Wik; Ingunn Marie Stefansson et al. (2009). Stathmin is superior to AKT and Phospho-AKT staining to detect PI3Kinase activation and aggressive endometrial cancer. (ekstern lenke)
• Jenny Hild Aase Husby; Bernt Reitan; Jone Trovik et al. (2014). Metabolic tumor volume on FDG-PET/CT predicts deep myometrial invasion, lymph node metastases and survival in patients with endometrial carcinoma. (ekstern lenke)
• Charlotte Nilsen; Mona Lunestad; Ingeborg Bøe Engelsen et al. (2015). Nasogastric feeding in hyperemesis gravidarum; tube positioning by ward nurse, a pilot study. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Helga Birgitte Salvesen; Ingfrid S. Haldorsen; Jone Trovik (2012). Markers for individualised therapy in endometrial carcinoma. (ekstern lenke)
• Marlena Schoenberg Fejzo; Jone Trovik; Iris J. Grooten et al. (2019). Nausea and vomiting of pregnancy and hyperemesis gravidarum. (ekstern lenke)
• L. M. van der Minnen; I.J. Grooten; C. Dean et al. (2025). The impact and management of hyperemesis gravidarum: Current and future perspectives. (ekstern lenke)

Doktorgradsavhandling

• Jone Trovik (2012). Endometrial carcinoma; can biomarkers aid in the prediction of aggressive disease? A study with focus on preoperative tumour markers. (ekstern lenke)

Medieintervju

• Sveinung Wergeland Sørbye; Jeanette Stålcrantz; Jone Trovik et al. (2014). - Alle kvinner bør ta denne vaksinen. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin